Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Microbial cell envelopes and osmotic balance refer to the complex structural and physiological systems that protect microorganisms from environmental stress and maintain internal pressure. In bacteria, this includes the cytoplasmic membrane, the peptidoglycan cell wall, and, in Gram-negative species, an additional outer membrane. These structures are essential for survival, as they prevent cell lysis caused by the high internal osmotic pressure relative to the external environment. Because many components of the microbial cell envelope, such as peptidoglycan, are absent in mammalian cells, they serve as highly effective targets for selective toxicity in antimicrobial therapy. Drugs targeting these systems either inhibit the assembly of the structural framework or directly disrupt the lipid bilayers, leading to a catastrophic loss of osmotic control and rapid cell death. This target area is fundamental to the treatment of a wide range of bacterial and fungal infections, though its efficacy is increasingly challenged by the evolution of microbial resistance mechanisms that modify envelope components or pump out therapeutic agents.
Drugs targeting this system typically act by inhibiting peptidoglycan biosynthesis (beta-lactams, glycopeptides), disrupting the integrity of the cytoplasmic or outer membrane (polymyxins, lipopeptides), or inhibiting the synthesis of fungal cell wall components like beta-glucan (echinocandins). These actions lead to the loss of osmotic balance, resulting in cytoplasmic leakage and cell lysis.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microbial cell envelopes and osmotic balance.